The datasets tested represented: (i) a collection of 171 prostate samples, which included normal and transformed tissues [51], (ii) 94 breast tumors [52], and (iii) CD138+ cells purified from the bone marrow of 50 multiple myeloma (MM) patients [53]. This evidence concerns the gene SDC1 and breast neoplasm.